| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $15.4M | -41.2% |
| SG&A Expense | $24.9M | +31.4% |
| Operating Income | -$40.3M | +10.8% |
| Income Tax | $0 | — |
| Net Income | -$35.1M | +22.4% |
| EPS (Basic) | -$1.30 | +24.4% |
| EPS (Diluted) | -$1.30 | +24.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $93.1M | +113.6% |
| Short-term Investments | $13.7M | -82.9% |
| Current Assets | $110.3M | -18.0% |
| Total Assets | $110.5M | -18.2% |
| Current Liabilities | $2.8M | -53.5% |
| Total Liabilities | $2.9M | -54.3% |
| Stockholders' Equity | $107.6M | -16.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$20.6M | +44.9% |
| Investing Cash Flow | $69.0M | +100.3% |
| Financing Cash Flow | $841K | — |